Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter L. Buzy currently holds 45,950 shares of MARTEK BIOSCIENCES CORP (MATK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter L. Buzy has been a net buyer of MATK stock. They have purchased $2.1M and sold $1.1M worth of shares.
Peter L. Buzy's most recent insider trade was on Apr 9, 2020, when they sold 266 shares at $56.46 per share.
Peter L. Buzy serves as Executive at MARTEK BIOSCIENCES CORP (MATK). They have executed 21 insider transactions totaling $3.2M over their tenure at the company.
Peter L. Buzy holds the position of Executive at MARTEK BIOSCIENCES CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Peter L. Buzy has shown a buying trading pattern, with $2.1M in total purchases and $1.1M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Peter L. Buzy was on May 29, 2019, when they purchased $2.0M worth of CTLT shares. This transaction involved 44,500 shares at $45.13 per share.
Peter L. Buzy currently owns 45,950 shares of MARTEK BIOSCIENCES CORP (MATK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter L. Buzy's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter L. Buzy has 21 Form 4 filings on record as an insider at MARTEK BIOSCIENCES CORP.
Set alerts for Peter L. Buzy and 40,000+ other insiders.